GenScript Life Science Research Grant Program (Rising Star Grant)

GenScript Life Science Research Grant Program (Rising Star Grant) is sponsored by GenScript. The Rising Star Grant supports emerging innovators who are establishing their path and shaping the next generation of scientific progress in life sciences, including areas relevant to RNA sequencing technology.

GenScript Life Science Research Grant Program Ask me about GenScript services and products! I can answer questions or connect you to a live person. Up to $1.

5M Funding Pool Technical Expertise The GenScript Life Science Research Grant (GenScript LSRG) is the global initiative for life science innovation , providing $1. 5 million in annual funding to support researchers shaping the future of life science. Many promising ideas face real challenges, not because they lack merit, but because researchers limited access to funding, infrastructure, and the right scientific ecosystem.

By combining funding, scientific expertise , and global ecosystem access , ideas develop, scale, and move toward real-world impact whether you're advancing AI-powered drug discovery, and gene therapies, vaccines, diagnostics, biologics , or other research areas. Supports ambitious, high-impact innovation with the potential to drive meaningful advances in global health and life sciences.

​ The Global Pioneer Grant supports bold ideas grounded in strong real-world relevance, helping innovations progress toward broader impact. Supports emerging innovators who are establishing their path and shaping the next generation of scientific progress.

​ The Rising is designed for researchers and innovators at earlier stages of their career or new directions of their work, those building momentum and bringing fresh perspectives to Designed for innovators applying artificial intelligence to accelerate the discovery and development of new therapeutics.

The AI Drug Discovery Frontier Grant supports innovators that use AI, machine computational modeling, or data-driven platforms to advance key stages of drug A fast-track opportunity for early breakthrough concepts ready to be discovered. The Spark Pitch Grant supports university, investor-facing innovators with high-potential ideas at an early stage.

Through a pitch-based format and streamlined review, this award provides seed funding and visibility to help promising concepts take their first step toward validation, This tier follows an offline, event-based application and selection process. Online applications are not accepted. Eligibility, event details, and award announcements will be shared separately.

Technical Support & Solutions Access to GenScript expertise, technologies, and solutions to support project execution. Connect with scientific peers, industry experts, and broader research communities through conferences and GenScript hosted events. Opportunities to showcase your work through GenScript From application to impact, we support you every step of the way.

Submit your research proposal and Applications are evaluated through process based on scientific merit, innovation, feasibility, Selected applicants are announced as GenScript LSRG awardees and receive next-step guidance from the GenScript team. Awardees complete the onboarding process and begin leveraging their grants, gaining access to funding, scientific resources, and the GenScript LSRG ecosystem.

As projects progress, GenScript continues to support awardees with technical expertise and opportunities for visibility and recognition, helping ideas move forward and reach greater impact.

Path to Your GenScript Life Science Research Researchers We’ve Supported “The GenScript LSRG grant has been instrumental in advancing KiraGen Bio’s discovery platform for multiplex gene editing in CAR-T cell “This grant has allowed Ikarovec to expand our in vivo anti-fibrotic evaluation, which in turn will help complete a full data package suitable for clinical development.

” "The BLI assays performed at GenScript allow us to show that our in-silico protein design process is able to design binders at very high success probability. We can now use the results of this assay to guide our designs in the following cellular assays." “Thanks to the GenScript LSRG grant, we could expand our repertoire of de novo synthesis to 100 synthetic sequences, and have them all synthesized and shipped to us.

An endeavor otherwise not possible for an academic “This funding is enabling the development of a critical research tool that I hope will generate key preliminary data to support further studies and unlock additional opportunities for larger-scale funding to "This GenScript LSRG grant provides me with the funding to kick-start a high-risk, high-reward research project that is at the forefront of cancer immunotherapy.

GenScript’s high quality and rapid plasmid, mRNA and AAV services has drastically reduced the time it has taken to translate ideas into real-world feasibility data which will attract further funding and The University of Melbourne Contreras Biostone Animal Health LLC Linghu University of Michigan University of Illinois at Chicago Chiesa University of Toronto Research and Innovation Center Stanford University School of Medicine Maganti Canadian Blood Services GUO Dr. David Schaffer lab Sek The University of Melbourne Oslo universitetssykehus HF University of Pennsylvania University of the Witwatersrand Huang Stanford University Schmidt Medical University of Vienna TargetGene Biotechnologies LTD Pollak ProtOS Nanomachines Ltd Ho Agency for Science Technology Vidyasirimedhi Institute of Science and Technology Zwiegelaar Azargen Biotechnologies Baylor College of Medicine UMass Medical School (UMMS) University College London North- West University, South Africa University of South Bohemia University of the Witwatersrand University of California, Korea Institute of Science and University of Maryland, Baltimore (UMB) Polytechnique Fédérale de Lausanne Antibody Drug Development Medical College of Wisconsin (MCW) Batchu Wayne State University City of Hope National Medical Center Balan Icahn School of Medicine at Virologie und Immunologie(IVI) Klinikum der Universität MünchenRegion LMU Munich Munich, German Tokyo University of Agriculture and Leiden University Medical Center (LUMC) - Instituto de Investigação e Inovação da Universidade do Porto Massachusetts Institute of University of Southern California University of Miami - Miller MD Anderson Cancer Center Siren Biotechnology, Inc. National Research Council of Christensen Children's Hospital TRAN Medical Genetics Institute Mammano University of Padova, Dept.

Loncarevic QUANTBIORES A/S (QBR) Mates Biological Research Center, Ugalde Onena Medicines S. L.

IRCCS Cà Granda, Ospedale Maggiore Policlinico Milano, Lombardia University in Saint Louis Shahbazi Indiana University School of University of California, San Francisco gomez-sebastian Universidad Autonoma de Madrid Biosciences Department, Human Health Therapeutics, National Research Council University of Melbourne, Florey Department of Neuroscience and Mental Health Hasegawa KAZUSA DNA Research Institute Phase0, Inc. DBA Sift Biosciences Sheng Columbia University Irving Lee Fred Hutchinson Cancer Research University of California, San Francisco ClearVision Therapeutics, Inc University of Pennsylvania University of California, Berkeley Nickel Swiss Federal Institute of Technology Lausanne (EPFL) University of Pennsylvania (UPenn) Fernandez-Quintero Scripps Research Pek Cincinnati Children's Hospital Lilium Therapeutics Inc (Labcentral) Poulopoulos University of Maryland Ferraris University of Eastern of Applied Microbiology and Biotechnology (LAMB), University of Antwerp Riccabona Institute of Drug Discovery, Leipzig University Institute for Integrative Cancer Research at MIT, Massachusetts Institute of California, San Francisco and UC Berkeley Wielendaele University of Antwerp, lab of Medical Biochemistry Perrotta Harvard Medical School (HMS) Vincent Macquarie University University of New South Wales Yarov-Yarovoy University of California, 1.

What is the GenScript Life Science Research Grant (GenScript LSRG) The GenScript Life Science Research Grant (GenScript LSRG) Program is a global initiative established to support breakthrough life science research and accelerate scientific innovation.

More than a funding program, GenScript LSRG serves as an innovation platform by combining grant funding, scientific expertise, and access to GenScript's global ecosystem to help promising ideas develop, scale, and achieve real-world impact.

At its core, the program reflects GenScript's commitment to empowering researchers and advancing innovation across diverse fields, including AI drug discovery, antibody drug discovery, cell and gene therapy, vaccine development, diagnostics, biologics , and other emerging areas of life science research. 2.

What research areas are funded by the GenScript Life Science Research The grant supports researchers engaged in projects that can significantly contribute to critical areas of life science research, including, but not limited to, AI- drug discovery (AIDD), antibody development, cell and gene therapy, vaccines, diagnostics, and biologics.

In addition to the general research grant, GenScript LSRG also offers a special AI Drug Discovery Frontier Grant dedicated exclusively to projects focused on AI-driven drug 3. Do I need to register at GenScript. com to apply for the GenScript Life Registration at GenScript.

com is necessary to complete the grant application form through the dedicated portal at https://www. genscript. com/grantprogram-form.

html . Any question related to application please email to LSRgrant@genscript. com.

4. How do I apply for the GenScript Life Science Research Grant? Applicants may directly apply by accessing the online application portal at https://www.

genscript. com/grantprogram-form. html .

And this is the only way to apply for GenScript LSRG 2026 since it ensures fast and accurate processing of your application materials. 5. Who should I contact for more information about the GenScript Life Science Research Grant Program?

For any questions regarding the GenScript Life Science Research Grant Program, please contact us at LSRgrant@genscript. com . Our team will be happy to assist you.

6. Who should I contact if I have questions about my project’s For any questions regarding the GenScript Life Science Research Grant Program, please contact us at LSRgrant@genscript. com .

Our team will be happy to assist you. 7. Who should I contact to update my application information?

For any questions regarding the GenScript Life Science Research Grant Program, please contact us at LSRgrant@genscript. com . Our team will be happy to assist you.

8. How is my application evaluated? Applications will be evaluated confidentially by an internal panel of experts.

Review criteria include scientific merit, innovation, feasibility, potential impact, project timeline, and use of GenScript reagents and services. 9. Who evaluates my application for the GenScript Life Science Research GenScript has designated an internal committee dedicated to the grant evaluation process.

All grant applications will be reviewed in a fully confidential manner. 10. Can I provide supporting materials for my GenScript Life Science Research Grant application?

Supporting materials are optional and may be submitted through the application portal 11. What is the “Research Proposal” under optional supporting The “Research Proposal” is an optional file that may be uploaded as part of your application. For example, to share more insight into the research scope or to provide supporting preliminary data.

You don’t need to submit a separate proposal. 12. What type of supporting materials may be included with my Supporting materials may include a Research Proposal (PDF), a Curriculum Vitae (CV) for each team member (PDF), an Itemized Budget Request (PDF), or any additional relevant documents.

13. Who can apply for the GenScript Life Science Research Grant? The program is open to researchers worldwide.

There are no restrictions on geographic location, and international applicants are encouraged to apply. Eligible applicants include academic/research institutions, universities, biotechnology companies, and other organizations engaged in life science research. Please note: Local, state, provincial, and government officials, as well as employees thereof, are not eligible.

Healthcare organizations (including hospitals, healthcare professionals, and their employees) may also be ineligible. 14. Can I use my award for salaries or services and reagents from other No, this grant is designed to provide funding explicitly designated for purchasing GenScript reagents and services.

Funds are not available to cover indirect costs, such as salaries, or to purchase services and products from other companies. 15. How long is the review process for the GenScript Life Science Research Award announcements are expected within 10 weeks of submission deadline.

16. What are the funding levels for the GenScript Life Science Research For GenScript LSRG 2026, please find the award description and monetary value for each award here GenScript Life Science Research Grant 17. Once the award is granted, when is a project required to start?

Projects are expected to commence promptly, within six months after receiving grant funding from GenScript. 18. Who owns the IP from work funded by the GenScript Life Science Research The awardee owns all rights to IP made in the performance of Services under the 19.

What does the “Contract” as the last step of the application workflow To finalize the application procedure, the GenScript team will present a "collaboration agreement" for review by the grant recipients. Awardees will be asked to consent to allow GenScript and its partners to disseminate details about their research projects and affiliations for promotion and marketing purposes.

This will be in coordination with the investigators and according to publication schedules. Moreover, the contract will specify additional measures to recognize GenScript's contributions in diverse forums publicly. Some examples include public posters or oral presentations, potential publications that employ data generated from the proposed project, co-author publications, webinars, and sponsored talks at international conferences.

20. Are postdoctoral fellows or scholars eligible to apply to the Life Science Research Grant Program? Postdoctoral fellows and investigators transitioning to independent laboratories can apply directly to the Life Science Research Grant; however, applications must include their current principal investigator, mentor, or supervisor as part of the research team.

Including a PI in the application process ensures: 1) Agreement on how awarded funds are used towards GenScript Reagents and 2) Compliance with the Life Science Research Grant Program conditions of participation in post-award marketing activities to publicly recognize GenScript's contributions in diverse forums 21.

What does “only one application may be submitted per entity” The entity refers to the laboratory or group under the direction of a specific principal investigator or involving the same investigator in a group. Multiple independent principal investigators from the same institution may apply to the GenScript Life Science 22. I’m not familiar with GenScript reagents and services.

How can I apply for the Life Science Research Grant (GenScript LSRG)? The Life Science Research Grant (GenScript LSRG) is designed to support your research through GenScript’s advanced scientific services. Even if you’ve never used GenScript reagents or services before, you are welcome to apply.

We recommend visiting www. genscript. com and exploring our dedicated Reagent Services pages to learn more about the platforms, technologies, and solutions we offer.

These pages allow you to request quotes for specific services and connect directly with our experienced technical teams, ensuring you receive the most suitable support for your research needs. As a global leader in biotechnology, GenScript has regional representatives who can provide one‑on‑one consultation to help you navigate service selection and budget planning.

You can find your local representative via our Contact GenScript LSRG funding is particularly well‑suited for supporting specific aims within a larger, more comprehensive project, especially when those aims are currently limited by insufficient funding or a lack of in‑house advanced technologies and expertise. Our goal is to help you overcome these barriers and accelerate your scientific progress. 23.

Do GenScript LSRG applications and funded proposals remain confidential, and have the grant reviewers signed confidentiality agreements? GenScript LSRG applications are processed and reviewed by an internal committee.

While reviewers do not sign a specific GenScript LSRG program confidentiality agreement, all of our applicants' information is protected by the employee information security rules that require them to keep project information confidential stringently. 24. Is the tax on services or material costs covered within the budget of the GenScript LSRG award?

The cost associated with taxes for services and reagents is covered by the funds provided through the GenScript LSRG program. 25.

Is a collaborator needed to submit an GenScript LSRG application, or is a list of graduate students, postdoctoral researchers, and others involved in the project Having external collaborators is not a requirement for applying to the GenScript LSRG program but must be listed if such partners are involved in the submitted proposal. Including lab members involved in the project is sufficient for the program’s 26.

Can GenScript LSRG applicants review the 'collaboration agreement' before submitting an application to the program? The collaboration agreement will not be shared with applicants. Once funding decisions are made, the agreement will be made available to the award recipients.

The agreement gives investigators a lot of flexibility to decide how much they will engage in marketing activities with GenScript (e.g., webinars, presentations at events, developing 27. We are confused about the following statement: “ Compliance with all applicable federal, state, and local laws and regulations.

” As this is a global opportunity, the wording in the application materials is meant to be inclusive of applicants from different regions. The requirement to comply with applicable laws refers to the laws relevant to each applicant’s location. For example, U.S. federal and state laws apply only to U.S.-based applicants, while those in the EU, APAC, or other regions would follow the legal requirements of their respective jurisdictions.

28. Are GenScript LSRG awards provided as a credit, meaning no funds are provided to awardees directly? ” Yes.

The GenScript LSRG grant is awarded in the form of credits that can be used for services at GenScript. No cash or direct funds will be issued to awardees, in accordance with program policies. 29.

Are shipping costs for delivery of reagents covered by the GenScript No. Shipping costs are generally not included in GenScript LSRG award funding and will need to be covered separately by the awardee. 30. My institution is a tax-exempt organization, will I incur on tax payments with the GenScript LSRG award?

For organizations that meet the legal requirements for tax exemption in their jurisdiction and provide valid documentation, sales tax or VAT will not be applied to quotes for services covered by GenScript LSRG funds. Tax policies are subject to local laws and regulations. 31.

Will I receive a notification when my GenScript LSRG coupon balance is running low or close to zero? Yes. A notification email will be sent when your GenScript LSRG coupon balance is running low, so you can monitor and manage your remaining credits accordingly.

32. Do I need to remove my coupon from an existing quotation before applying it to a new quotation? Yes.

If a coupon is still applied to an existing quotation, the associated credits will remain allocated to that quotation. To use the credits for a new quotation, please remove the coupon from the existing quotation first. Do you like the current new website?

* Enter your email address if you would like to receive a follow up